Article Details

High hopes for mRNA anti-cancer vaccines, with Moderna and Merck touting success

Retrieved on: 2022-12-15 16:18:47

Tags for this article:

Click the tags to see associated articles and topics

High hopes for mRNA anti-cancer vaccines, with Moderna and Merck touting success. View article details on hiswai:

Excerpt

There are multiple mRNA vaccines in development for a range of oncology indications, including Moderna and Merck's Keytruda.

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up